BioWednesday Cambridge: Joint One Nucleus and BioMed Realty Autumn Social

Prior to the start of our BioWednesday we will be hosting a Brexit Business Readiness Update from 17:00 to 17:45pm

Chaired by Tony Jones, CEO One Nucleus, this session will recap from the OLS recent seminar on 3^rd October and the following Q&A mainly on Regulatory, Taxation and Employment. It will provide attendees with the most up to date information on Brexit possible impacts on business operations and will be the opportunity to raise concerns on business readiness that can be fed back to the office for life sciences.

If you would like to attend this event, please email alicia@onenucleus.com

Our social event in collaboration with BioMed Realty on Granta Park will open with a short presentation on BioMed, Granta Park and their new space at Babraham Research Campus in Cambridge, UK and what this expansion means for the local life science community.  We then invite you to open networking over drinks and canapes.  It is an excellent opportunity to meet with our friendly network in a relaxed atmosphere all whilst enjoying some refreshments.

Programme

17:00 Arrival

17:10 Brexit Business Readiness Update

17:45 BioWednesday Start – Registration and Networking

18:00 Welcome from hosts

18:05 Introduction to BioMed Realty, Granta Park and new space at Babraham
Michael Jones, Director, Head of Commercial Division, Cheffins
Orestis Tzortzoglou, Development Director, BioMed Realty

18:20 Networking over drinks and canapes

20:30 Close

About BioMed Realty

BioMed Realty, a Blackstone portfolio company, is The Leading Provider of Real Estate Solutions to the Life Science Community. BioMed owns and operates high quality life science real estate comprising 11 million square feet located in the leading innovation markets throughout the United States and United Kingdom, led by Boston-Cambridge, San Francisco, San Diego, Seattle, New York and Cambridge U.K.  BioMed at Babraham is BioMed’s latest U.K. development, offering first class fitted flexible laboratory and office space for users 12,500 square feet upwards, in addition to access for growth opportunities within BioMed’s nearly 1 million square foot life science portfolio in the U.K.

**This button will not work if you are not logged in**